FilingIndex
← The Wire
GNLXNasdaq

GENELUX Corp

Pharmaceutical Preparations · DE · CIK 1231457

GENELUX Corp develops next-generation oncolytic viral immunotherapies for aggressive and difficult-to-treat cancers

$133M
Market cap
$2.90
Last close
+1.1%
1D
-0.7%
5D
200K
Volume
Price · last 39 sessions+1.8%
May 4L $2.77 · H $3.19Jun 29
74
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end

Insider Activity

In the 90 days to Mar 25, 2026: 5 sold $43K.

DateInsiderActionSharesPriceValue
Mar 25, 2026Smalling RalphHead of RegulatorySell240$2.51$602
Mar 24, 2026Zindrick ThomasPresident and CEOSell3,582$2.42$9K
Mar 24, 2026Yu YongSVP, Clinical DevelopmentSell906$2.42$2K
Mar 24, 2026Cappello JosephChief Technical OfficerSell906$2.42$2K
Mar 24, 2026Smalling RalphHead of RegulatorySell345$2.42$835
Mar 2, 2026Thomas JohnDirectorSell10,000$2.90$29K
Dec 5, 2025Smalling RalphHead of RegulatorySell165$4.69$774
Dec 1, 2025Thomas JohnDirectorSell10,000$5.00$50K
Nov 17, 2025Zindrick ThomasPresident and CEOSell4,509$5.37$24K
Nov 17, 2025Yu YongSVP, Clinical DevelopmentSell973$5.37$5K
Nov 17, 2025Cappello JosephChief Technical OfficerSell973$5.37$5K
Nov 17, 2025Smalling RalphHead of RegulatorySell343$5.37$2K
Sep 3, 2025Smalling RalphHead of RegulatorySell580$3.36$2K
Aug 21, 2025Zindrick ThomasPresident and CEOSell12,673$3.33$42K
Aug 21, 2025Yu YongSVP, Clinical DevelopmentSell3,219$3.36$11K
Aug 21, 2025Cappello JosephChief Technical OfficerSell1,463$3.36$5K
Aug 21, 2025Cappello JosephChief Technical OfficerSell1,270$3.33$4K
Aug 21, 2025Smalling RalphHead of RegulatorySell1,244$3.36$4K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance